GO:2000143 negative regulation of DNA-templated transcription initiation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000143 describes any process that stops, prevents, or reduces the frequency, rate, or extent of DNA-templated transcription initiation.
• Transcription initiation is the first and most heavily regulated step of gene expression, making its negative regulation central to developmental decisions and stress responses.
• Key repressive mechanisms include chromatin compaction, sequestration or modification of general transcription factors, and promoter competition.
• Dysregulation of transcription initiation is linked to diseases such as cancer, where oncogenes escape repression, and to developmental disorders.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of repressive circuits.
• Combining CRISPR screening with RNA-seq, ChIP-seq, and reporter assays provides a systematic way to map negative regulators of initiation.
Description
The Gene Ontology term GO:2000143, negative regulation of DNA-templated transcription initiation, defines any process that stops, prevents, or reduces the frequency, rate, or extent of DNA-templated transcription initiation. Transcription initiation is the step at which RNA polymerase and general transcription factors assemble on a promoter to begin RNA synthesis, and it is a major control point for gene expression. Because inappropriate initiation can drive oncogenesis or developmental defects, cells deploy multiple layers of negative regulation to keep initiation in check. Understanding these repressive mechanisms is therefore essential for both basic biology and therapeutic development. Research into negative regulation of transcription initiation spans chromatin biology, transcription factor dynamics, and signal transduction. For example, during early follicular atresia in pig ovaries, gene networks that include transcriptional repressors are activated to shut down specific gene programs. In model systems such as Saccharomyces cerevisiae, DNA-directed expression of viral RNA can be used to study replication-dependent colony formation, providing a tractable readout for initiation control. These studies highlight the diversity of biological contexts in which negative regulation of initiation operates. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:2000143. It covers the molecular events that constitute negative regulation, the genes and proteins involved, disease associations, and the experimental models, including CRISPR-based approaches, that are used to study this process.
negative regulation of DNA-templated transcription initiation At A Glance
| GO ID | GO:2000143 |
|---|---|
| GO term | negative regulation of DNA-templated transcription initiation |
| Ontology | biological_process |
| Synonym | negative regulation of transcription initiation, DNA-dependent; negative regulation of DNA-dependent transcription, initiation; negative regulation of initiation of DNA-dependent transcription |
| Major function | Reduces the frequency, rate, or extent of transcription initiation, thereby controlling gene expression output |
| Biological context | Operates in developmental decisions, stress responses, and cell-fate specification |
| Regulatory layer | Acts at the level of promoter recognition and pre-initiation complex assembly |
| Disease relevance | Dysregulation is associated with cancer and developmental disorders |
| Experimental models | CRISPR knockout, point mutation, knock-in, overexpression, and reporter assays |
What Is GO:2000143?
GO:2000143, negative regulation of DNA-templated transcription initiation, is a biological process that encompasses any mechanism that stops, prevents, or reduces the frequency, rate, or extent of the initiation step of DNA-templated transcription. In other words, it includes all cellular strategies that dampen or block the assembly of the transcription initiation complex at a promoter, thereby reducing the production of RNA transcripts.
Why Is negative regulation of DNA-templated transcription initiation Important in Cell Biology?
Negative regulation of DNA-templated transcription initiation is critically important because it provides a primary layer of control over gene expression, allowing cells to silence inappropriate or untimely transcription. This process ensures that genes are expressed only when needed, and its failure can lead to uncontrolled proliferation, developmental abnormalities, or impaired stress responses. Moreover, many signaling pathways converge on transcription initiation to reprogram gene expression, making this term a hub for understanding how extracellular cues are translated into cellular decisions.
• Controls the first committed step of gene expression, determining which genes are active.
• Enables rapid and reversible responses to developmental and environmental signals.
• Prevents spurious transcription that could be deleterious to the cell.
• Plays a role in cell-fate decisions, including differentiation and apoptosis.
• Dysregulation is implicated in cancer, where repression of tumor suppressors or oncogenes is lost.
• Contributes to tissue homeostasis, as seen in ovarian follicular atresia.
• Provides a target for therapeutic intervention in diseases of gene dysregulation.
• Can be studied using viral-based reporter systems in yeast.
• Serves as a paradigm for understanding combinatorial control of transcription.
• Is essential for normal development and organ function.
What Happens During negative regulation of DNA-templated transcription initiation?
Promoter recognition and pre-initiation complex assembly
In simple terms: Before transcription can start, a large molecular machine must assemble on the DNA; negative regulation often blocks this assembly.
Transcription initiation begins with the recognition of promoter DNA by general transcription factors and RNA polymerase II, leading to the formation of the pre-initiation complex (PIC). Negative regulation of initiation frequently targets this step by preventing the recruitment or stability of PIC components. For example, repressors can bind to promoter-proximal elements and compete with or displace general transcription factors, thereby reducing the frequency of initiation. In the context of early follicular atresia, gene networks involving transcriptional repressors are activated to downregulate specific genes, illustrating how PIC assembly can be inhibited in a physiological setting.
Chromatin-mediated repression
In simple terms: DNA is wrapped around proteins; when it is tightly packed, the transcription machinery cannot access it.
Chromatin structure plays a dominant role in regulating transcription initiation. Negative regulation can occur through chromatin compaction, which restricts access of transcription factors and RNA polymerase to promoters. This is often mediated by histone modifications such as deacetylation or methylation, and by the action of chromatin remodeling complexes that shift nucleosomes to occlude promoter elements. In pig ovaries during early atresia, changes in gene networks likely involve chromatin-based silencing of specific genes, contributing to the initiation of atresia.
Sequestration and modification of transcription factors
In simple terms: Cells can lock away or chemically alter the proteins needed for transcription, so they cannot do their job.
Another key mechanism of negative regulation is the sequestration or post-translational modification of transcription factors required for initiation. For instance, inhibitory proteins can bind to activators and prevent them from interacting with the basal transcription machinery. Phosphorylation, ubiquitination, or sumoylation of transcription factors can also reduce their activity or promote their degradation, thereby lowering initiation rates. Such mechanisms allow for rapid and reversible control of gene expression in response to signals.
Promoter competition and transcriptional interference
In simple terms: When two transcription start sites are close, one can block the other.
In some cases, negative regulation of initiation arises from competition between overlapping promoters or from transcriptional interference, where an upstream initiating polymerase interferes with downstream initiation. This can occur when a repressive non-coding RNA or a divergent transcript is produced, which can disrupt the assembly or activity of the initiation complex at a neighboring promoter. Such mechanisms contribute to the fine-tuning of gene expression and have been observed in various developmental contexts.
Signal-dependent repression
In simple terms: External signals can tell the cell to stop making certain RNAs.
Extracellular signals can trigger negative regulation of transcription initiation through signaling cascades that ultimately modify transcription factors or chromatin. For example, during early follicular atresia, hormonal and local signals activate gene networks that include repressors, leading to the shutdown of genes that maintain follicle viability. In yeast, DNA-directed expression of an animal virus RNA can be used to monitor replication-dependent colony formation, providing a model to study how initiation is negatively regulated under specific conditions.
Key Genes Involved in GO:2000143 negative regulation of DNA-templated transcription initiation
The following genes and proteins are representative participants in negative regulation of DNA-templated transcription initiation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Acts as a sequence-specific transcription factor that can repress initiation of target genes | Frequently mutated in cancers; loss of repression contributes to oncogenesis |
| RB1 | Recruits chromatin-modifying complexes to repress E2F-dependent initiation | Loss leads to uncontrolled cell cycle entry; model for retinoblastoma |
| HDAC1 | Histone deacetylase that compacts chromatin and reduces initiation | Target for epigenetic therapies; studied in cancer and development |
| DNMT1 | DNA methyltransferase that methylates promoters, blocking initiation | Involved in gene silencing; knockout models show reactivation of repressed genes |
| CTCF | Insulator protein that can block enhancer-promoter communication and initiation | Important for 3D genome organization; studied in developmental disorders |
| YY1 | Dual-function transcription factor that can repress initiation by recruiting co-repressors | Implicated in cancer and differentiation; used in reporter assays |
| E2F1 | Activator that can be sequestered by RB1, indirectly reducing initiation | Key cell cycle regulator; models of overexpression and knockout |
| MYC | Oncogenic transcription factor that can both activate and repress initiation | Amplified in many cancers; studied for its repressive roles |
| GATA4 | Transcription factor involved in ovarian gene networks during atresia | Model for follicular atresia; knockout in pig models |
| FOXO3 | Forkhead transcription factor that can repress initiation of target genes | Linked to longevity and stress responses; knockout models available |
| SMAD3 | Mediator of TGF-beta signaling that can repress initiation | Studied in fibrosis and cancer; point mutations used to dissect function |
| NCOR1 | Nuclear receptor co-repressor that recruits HDACs to inhibit initiation | Implicated in metabolic and developmental disorders |
| SIRT1 | NAD-dependent deacetylase that can repress initiation via chromatin modification | Target for aging and metabolism research |
| KDM5A | Histone demethylase that can repress initiation by altering chromatin marks | Involved in cancer and intellectual disability |
| BRCA1 | Tumor suppressor that can repress initiation at specific promoters | Mutations linked to breast and ovarian cancer |
| CTNNB1 | Beta-catenin, which can repress initiation in certain contexts via TCF/LEF | Wnt signaling; knockout and overexpression models |
| SP1 | Transcription factor that can both activate and repress initiation | Widely studied in gene regulation; point mutants available |
| YY1AP1 | Co-repressor that interacts with YY1 to inhibit initiation | Less studied; potential target for CRISPR screening |
How Is negative regulation of DNA-templated transcription initiation Regulated?
Negative regulation of DNA-templated transcription initiation is itself regulated by upstream signaling pathways and feedback loops. For example, stress-activated kinases can phosphorylate transcription factors, altering their ability to recruit co-repressors and thus modulating initiation. In ovarian follicular atresia, gene networks involving hormones and local factors orchestrate the repression of specific genes, demonstrating that this process is under tight physiological control. Additionally, viral proteins can interfere with host initiation machinery, as seen in yeast models where DNA-directed expression of viral RNA depends on replication and can be modulated.
negative regulation of DNA-templated transcription initiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer (Li-Fraumeni syndrome, many sporadic cancers) | Knockout and point-mutation cell lines; xenograft models |
| RB1 | Retinoblastoma, osteosarcoma | Knockout iPSCs; overexpression of RB1 in cancer cells |
| NCOR1 | Developmental delay, intellectual disability | Knockout mice; patient-derived iPSCs with point mutations |
| KDM5A | Intellectual disability, cancer | Knock-in of patient mutations; CRISPR screening |
| GATA4 | Ovarian dysfunction, follicular atresia | Pig knockout models; overexpression in granulosa cells |
Cancer
Dysregulation of negative regulation of transcription initiation is a hallmark of cancer. Loss of repressive mechanisms can lead to overexpression of oncogenes or silencing of tumor suppressors. For instance, mutations in TP53 or RB1 impair their ability to repress initiation at target promoters, contributing to uncontrolled proliferation. Targeting the repressive machinery, such as HDACs or DNMTs, is a therapeutic strategy in several cancers.
Developmental disorders
Proper negative regulation of initiation is essential for normal development. Mutations in genes encoding repressors or chromatin modifiers can cause developmental syndromes. For example, haploinsufficiency of NCOR1 or KDM5A has been linked to intellectual disability and developmental delay. Studying these genes in model organisms helps elucidate how initiation repression contributes to tissue patterning.
Reproductive disorders
In the ovary, negative regulation of transcription initiation is involved in follicular atresia, a process of programmed cell death that eliminates excess follicles. Gene networks during early atresia in pigs show coordinated repression of genes that support follicle survival. Understanding these mechanisms may provide insights into reproductive disorders such as premature ovarian insufficiency.
Viral infections
Viruses often hijack or counteract host transcription initiation. The DNA-directed expression of an animal virus RNA in Saccharomyces cerevisiae demonstrates how viral elements can be used to study replication-dependent colony formation, which is linked to initiation control. Such models help identify host factors that negatively regulate viral transcription initiation.
From negative regulation of DNA-templated transcription initiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate repressor increase initiation at target promoters? | CRISPR knockout followed by RNA-seq and ChIP-seq |
| Does a specific point mutation in a transcription factor alter its repressive activity? | CRISPR point mutation knock-in |
| Can a repressor be tagged to study its genomic binding dynamics? | CRISPR knock-in of an epitope tag |
| Does overexpression of a repressor reduce initiation and affect cell phenotype? | CRISPR overexpression (e.g., CRISPRa) or lentiviral overexpression |
| Which genes are essential for negative regulation of initiation in a disease context? | Genome-wide CRISPR knockout library screening |
| How does a repressor respond to signaling cues? | Reporter assays combined with CRISPR knockout of signaling components |
How to Study the negative regulation of DNA-templated transcription initiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state RNA levels | Global changes in gene expression upon repressor knockout |
| PRO-seq / GRO-seq | Nascent RNA and initiation frequency | Direct measurement of initiation at promoters |
| ChIP-seq | Protein-DNA binding | Occupancy of RNA polymerase II and transcription factors at promoters |
| ATAC-seq | Chromatin accessibility | Assessing promoter accessibility after perturbation |
| Reporter assay | Promoter activity | Quantifying initiation rate in response to repressor loss |
| Co-IP / mass spectrometry | Protein-protein interactions | Identifying repressor complexes |
| CRISPR screening | Gene essentiality or phenotype | Genome-wide identification of negative regulators of initiation |
| Flow cytometry | Cell phenotype and reporter fluorescence | Sorting cells with altered initiation for downstream analysis |
Transcriptomics and nascent RNA profiling
RNA-seq and nascent RNA labeling (e.g., GRO-seq, PRO-seq) can measure changes in transcription initiation at a genome-wide scale. By comparing wild-type and CRISPR knockout cells, researchers can identify promoters whose initiation is derepressed upon loss of a negative regulator. These methods provide quantitative readouts of initiation frequency and are compatible with high-throughput screening.
Chromatin immunoprecipitation and sequencing
ChIP-seq for RNA polymerase II and general transcription factors can reveal occupancy at promoters, indicating initiation events. Combining ChIP-seq with CRISPR knockouts of candidate repressors helps determine whether a factor directly blocks PIC assembly. ATAC-seq can complement these data by assessing chromatin accessibility at promoters.
Reporter assays
Luciferase or fluorescent reporters driven by specific promoters are classic tools to study initiation in real time. CRISPR-mediated knockout or point mutation of repressor genes can be combined with reporter assays to quantify changes in initiation rate. These assays are scalable for high-throughput screening of chemical libraries or genetic perturbations.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify proteins that interact with repressors or with the initiation machinery. Proximity labeling (e.g., BioID) can map the interactome of a repressor in live cells. These approaches help define the molecular complexes that mediate negative regulation of initiation.
How CRISPR Can Be Used to Study GO:2000143 negative regulation of DNA-templated transcription initiation
Knockout
CRISPR knockout is used to delete candidate repressor genes and assess whether their loss increases transcription initiation at target promoters. By generating clonal knockout lines, researchers can perform RNA-seq and ChIP-seq to identify derepressed genes. This approach is particularly powerful for studying genes like TP53 or RB1, where loss of repression contributes to cancer phenotypes.
Point Mutation
CRISPR point mutation allows the introduction of specific amino acid changes to dissect the functional domains of repressors. For example, mutating phosphorylation sites in a transcription factor can reveal how signaling modulates its repressive activity. This precision is essential for understanding mechanism and for modeling patient-specific mutations.
Knock-in
Knock-in of epitope tags or fluorescent proteins enables real-time tracking of repressor localization and binding dynamics. Tagged knock-in lines can be used for ChIP-seq, imaging, and proteomics without the need for antibodies. This is valuable for studying low-abundance repressors or those with poor antibody availability.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive supraphysiological levels of a repressor to test whether it is sufficient to reduce initiation. Overexpression models are useful for gain-of-function studies and for validating repressors identified in screens. They can also be combined with reporter assays to quantify repression strength.
How EDITGENE Supports negative regulation of DNA-templated transcription initiation Research
Researchers studying negative regulation of DNA-templated transcription initiation-related genes often need to determine whether a candidate gene is causally involved in repressing initiation, and CRISPR-based models provide the most direct way to test this. EDITGENE offers a comprehensive suite of services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of DNA-templated transcription initiation research.
Frequently Asked Questions About negative regulation of DNA-templated transcription initiation
What is GO:2000143?
GO:2000143 is the Gene Ontology term for negative regulation of DNA-templated transcription initiation, describing any process that stops, prevents, or reduces the initiation of transcription.
What genes are involved in negative regulation of DNA-templated transcription initiation?
Genes such as TP53, RB1, HDAC1, DNMT1, and NCOR1 are involved in repressing transcription initiation through various mechanisms.
How is negative regulation of transcription initiation studied?
It is studied using RNA-seq, ChIP-seq, reporter assays, and CRISPR-based perturbations to measure changes in initiation frequency.
Why is negative regulation of transcription initiation important?
It controls gene expression programs, prevents inappropriate transcription, and its dysregulation is linked to cancer and developmental disorders.
What are the mechanisms of negative regulation of transcription initiation?
Mechanisms include chromatin compaction, sequestration of transcription factors, promoter competition, and signal-dependent repression.
Which diseases are associated with defects in negative regulation of transcription initiation?
Cancer, developmental disorders, and reproductive disorders such as premature ovarian insufficiency have been linked to defects in this process.
Can CRISPR be used to study negative regulation of transcription initiation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of repressive mechanisms.
What model organisms are used to study negative regulation of transcription initiation?
Saccharomyces cerevisiae and mammalian cell lines, as well as pig models for ovarian atresia, are commonly used.
What is the role of chromatin in negative regulation of transcription initiation?
Chromatin compaction and histone modifications can block access of the transcription machinery to promoters, thereby reducing initiation.
How does EDITGENE support research on negative regulation of transcription initiation?
EDITGENE provides custom CRISPR knockout, point mutation, knock-in, overexpression cell models, and library screening services to study repressors of initiation.
Conclusion
GO:2000143, negative regulation of DNA-templated transcription initiation, is a fundamental biological process that controls gene expression at its earliest step. Its mechanisms range from chromatin-mediated repression to signal-dependent sequestration of transcription factors, and its dysregulation underlies various diseases. CRISPR-based models offer powerful tools to dissect these mechanisms and to identify new therapeutic targets. By combining precise genome editing with functional genomics, researchers can uncover how negative regulation of initiation shapes cellular decisions and contributes to disease. EDITGENE's suite of services supports these efforts with custom cell models and screening platforms.
References
- 1. Zhang J et al.. 2018. Initiation of follicular atresia: gene networks during early atresia in pig ovaries.. Reproduction 156(1):23-33 PMID: 29743261
- 2. Price BD et al.. 2002. DNA-directed expression of an animal virus RNA for replication-dependent colony formation in Saccharomyces cerevisiae.. J Virol 76(4):1610-6 PMID: 11799155